The Phase 3 Biotech Leadership Podcast: Recent Episodes
Alex Cooke
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from:
Hari Pujar - Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics
Randy Berholtz - Chair and Chief Executive Officer Chair and Chief Executive Officer - Rancho Santa Fe Bio, Inc.
Kameel Farag - CFO Aspen NeuroScience
Hosted by Jared Green and Alex Cooke from Phase 3 Search
www.ph3.bio
Our expert panel of hugley successful biotech C-leaders jump into best practices to ensure successful early fund raises in the biotech space. Having raised 100's of millions of dollars between them this is a great listen for all of those joining the fundraising roadshow.
Doug Carlson - Cheif Operating and Financial Officer - Avenge Bio
Mike Tusche - Co-CEO - Treadwell Therapeutics
Brian McVeigh - CEO - Code Biotherapeutics
Hosted by Jared Green and Alex Cooke from Phase 3 Search
www.ph3.bio
Our expert panel of exceptional leaders break down the top 5 traits that all high performing CMC teams have and those areas that are critical to focus on to ensure best results.
Panel members:
Mike Kamarck - Chairman of Sanofi, Biologics Board
Al Boyle - CTO of Alnylam
JD Mowery - COO, Treadwell Therapeutics
Hosted by Jared Green and Alex Cooke from Phase 3 Search
www.ph3.bio
In this interview, KG and I discuss the cultural and leadership challenges that biotech companies face as they go through exponential growth.
Drawing upon her experiences at Intercept Pharmaceuticals, Kite Pharmaceuticals and Turnstone Biologics she shares great insight into HOW companies can better serve and prepare themselves for growth.
A wide ranging interview with Carson Sublett who provides his perspective on what it takes to make it as a successful leader in the Biotech industry today.
We cover how he was able to transition from HR to Site Head by creating and empowering his teams.